Back to Search Start Over

Nicotinic receptors regulate B lymphocyte activation and immune response

Authors :
Jean-Pierre Changeux
Régis Grailhe
Marina V. Skok
Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine
National Academy of Sciences of Ukraine (NASU)
Récepteurs et Cognition (RC)
Collège de France (CdF (institution))-Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS)
Collège de France (CdF (institution))-Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)
Source :
European Journal of Pharmacology, European Journal of Pharmacology, Elsevier, 2005, 517 (3), pp.246-51. ⟨10.1016/j.ejphar.2005.05.011⟩, European Journal of Pharmacology, 2005, 517 (3), pp.246-51. ⟨10.1016/j.ejphar.2005.05.011⟩
Publication Year :
2005
Publisher :
HAL CCSD, 2005.

Abstract

International audience; The presence of nicotinic acetylcholine receptors (nicotinic receptors) composed of either alpha7 or alpha4 and beta2 subunits is revealed in B lymphocytes by means of radioligand binding assay and Cell ELISA. Mouse B lymphocytes contained 12,200+/-3200 of epibatidine-binding sites and 3130+/-750 of alpha-Bungarotoxin-binding sites per cell. Mice lacking nicotinic receptor subunits alpha4, beta2 or alpha7 had less serum IgG and IgG-producing cells in the spleen, but showed stronger immune response to both protein antigen in vivo and CD40-specific antibody in vitro than wild-type mice. Anti-CD40-stimulated proliferation of B lymphocytes from beta2 knockout, but not wild-type mice was inhibited with nicotine. Our results indicate that signalling through nicotinic receptors affects both the pre-immune state and activation of B lymphocytes in the immune response, possibly via CD40-dependent pathway. This could contribute to immune depression found in tobacco smokers.

Details

Language :
English
ISSN :
00142999
Database :
OpenAIRE
Journal :
European Journal of Pharmacology, European Journal of Pharmacology, Elsevier, 2005, 517 (3), pp.246-51. ⟨10.1016/j.ejphar.2005.05.011⟩, European Journal of Pharmacology, 2005, 517 (3), pp.246-51. ⟨10.1016/j.ejphar.2005.05.011⟩
Accession number :
edsair.doi.dedup.....4f5ece16c5427366d1f3a7a79cce1195
Full Text :
https://doi.org/10.1016/j.ejphar.2005.05.011⟩